GeneGlobe ID: JHS-3002Z | Cat. No.: | QIAseq RNA Fusion XP Panels

QIAseq RNA Fusion XP Pan Heme Panel

Kit containing ALL reagents (except indexes) for fusion and gene expression profiling by digital RNAseq

Select a variant to see the price

Product Specification

Target List

Leukemia
Acute Leukemia of Ambiguous Lineage​
ABL1, AFF1, BCR, CT45A2, ETV6, EWSR1, GPHN, KMT2A, MLLT10, MN1, NUP214, PBX1, SET, TCF3, ZNF384
Acute Lymphoblastic Leukemia (ALL)​
ABL1, ABL2 (ARG), ACTN4, AFDN, AFF1, AFF3, AFF4, AGGF1, ANLN, ASNS, ATF7IP, AUTS2, BCL11B, BCL9, BCR, BTBD18, CASC5, CREBBP (CBP), CRLF2 (TSLPR), CSF1R, DDX3X, EBF1, ELL, ELN, EML1, EP300, EPOR, EPS15, ESRRB, ETV6, EWSR1, FGFR1, FGFR1OP, FLT3, FOXO4, FOXP1, FRYL, GAS7, GPHN, HLF, HNRNPUL1, INPP5D, JAK2, KMT2A, KMT2E, LNP1, MAML2, MEF2D, MLLT1, MLLT10, MLLT3, MN1, MNX1, MYB, MYC, NCOA2, NOTCH1, NUP214, NUP98, P2RY8, PAG1, PAX5, PBX1, PCM1, PDGFRB, PICALM, PML, PRDM16, RAP1GDS1, RARA, RCSD1, RUNX1 (AML1), SALL2, SET, SFPQ, SPI1, SSBP2, STIL, STMN1, TAF15, TAL1, TCF3, TCF7, TET1, TYK2, USP9X, ZBTB16, ZCCHC7, ZMIZ1, ZMYM2, ZNF384, ZNF521, ATM, BRAF, CDKN2A (P16INK4A), CREBBP (CBP), CSF3R (GM-CSFR), DNM2, EGFR (ERBB1), FBXW7, GATA2, HRAS, MAP2K1, MLH1, PAX5, PDGFRA, PTEN, SMARCB1
Acute Myeloid Leukemia (AML)​
ABI1, ABI2, ABL1, AFDN, AFF1, AFF4, ALK, ANLN, ARHGAP26, ARHGEF12, BCOR, BCR, CASC5, CBFA2T3, CBFB, CBL, CCDC88C, CEP170B, CHD1, CHIC2, CREBBP (CBP), DAB2IP, DDX10, DEK, DHH, DIAPH2, ELL, EP300, EPS15, ERG, ETV6, FGFR1, FIP1L1, FLNA, FNBP1, FOXO3, FOXO4, FRYL, FUS, GAS7, GATA1, GLIS2, GPHN, HAUS1, HOXA9, HOXC11, HOXC13, HOXD13, IRF2BP2, JAK2, KAT6A, KDM5A, KIAA1524, KMT2A, LASP1, LNP1, LPP, LYN, MAML2, MECOM, MKL1, MLF1, MLLT1, MLLT10, MLLT11, MLLT3, MLLT6, MN1, MNX1, MYB, MYH11, MYO1F, NCKIPSD, NCOA2, NF1, NPM1, NSD1, NTRK3, NUMA1, NUP214, NUP98, PAN3, PBX1, PCM1, PDGFRA, PDGFRB, PDS5A, PHF23, PICALM, PML, PRDM16, PRRX1, PSIP1, PSMA2, PTPRR, RANBP2, RARA, RBM15, RHEBL1, RPL22, RPN1, RUNX1 (AML1), RUNX1T1, SARNP, SEPT2, SEPT5, SEPT6, SEPT9, SET, SH3GL1, SORBS2, STAT5B, TAF15, TCF3, TET1, TFG, TOP1, TOP3A, TRIP11, TYK2, UBA2, USP42, WHSC1L1, WTIP, ZBTB16, ZFYVE19, ZNF384, ASXL1, ATM, BCOR, BRAF, CDKN2A (P16INK4A), CHEK2 (RAD53), CREBBP (CBP), CSF3R (GM-CSFR), DAXX, DNM2, FLT3, GATA2, IDH1, IDH2, JAK1, JAK3, KIT (CD117), KMT2D, KRAS, MAP2K1, MPL, MYC, NRAS, PBRM1, PDGFRA, PPM1D, PTEN, PTPN11, RAD21, RET, RUNX1 (AML1), SMARCB1, SRSF2, U2AF1, WT1
Acute Myelomonocytic Leukemia (AMML)​
FLNA, HOXD13, NUP98
B-Cell Acute Lymphoblastic Leukemia (B-ALL)​
ABL1, ACTN4, AFF1, AFF3, AFF4, ATF7IP, BCR, BTBD18, CRLF2 (TSLPR), EPS15, ERG, ESRRB, ETV6, EWSR1, FUS, GAS7, JAK2, KMT2A, MAPRE1, MLLT1, NUP214, P2RY8, PAX5, PBX1, PCM1, RUNX1 (AML1), SET, SSBP2, TCF3, USP9X, ZNF384, ZNF521
Blast Phase Chronic Myeloid Leukemia​
ABL1, BCR, ETV6, JAK2
Chronic Eosinophilic Leukemia​
ACSL6, TNIP1
Chronic Lymphocytic Leukemia (CLL)​
MYC, NOTCH1, BRAF, CHEK2 (RAD53), CSF3R (GM-CSFR), MAP2K1, TERT
Chronic Myeloid Leukemia (CML)​
ABL1, BCR, CCDC88C, ETV6, HOXA11, HOXA13, JAK2, MECOM, MN1, NDE1, NUP98, PCM1, PDGFRB, RUNX1 (AML1), ABL1, CDKN2A (P16INK4A), CREBBP (CBP), CSF3R (GM-CSFR), FBXW7, GATA2
Chronic Myelomonocytic Leukemia (CMML)​
CREBBP (CBP), ELL, ETV6, KMT2A, MN1, CSF3R (GM-CSFR), HRAS, SRSF2
Myelodysplastic Syndromes (MDS)​
ABL1, ACTN4, ALK, CASC5, CREBBP (CBP), DEK, ERG, ETV6, FRYL, FUS, HOXD13, JAK2, KMT2A, LNP1, MAML2, MECOM, MLF1, MN1, MNX1, NDE1, NPM1, NUP214, NUP98, PCM1, PDGFRB, PRDM16, PTPRR, RANBP2, RUNX1 (AML1), RUNX1T1, TOP1, CDKN2A (P16INK4A), CSF3R (GM-CSFR), ETNK1, GNAS, HRAS, RAD21, SETBP1, SRSF2, U2AF1, XPO1, ZRSR2
Myeloproliferative Neoplasms​
ABL1, ACSL6, BCR, ETV6, FGFR1, FGFR1OP, FIP1L1, FLT3, HOXA9, HOXD13, JAK2, LYN, MECOM, MLF1, MN1, NPM1, NUP98, PDGFRB, PRKG2, PSIP1, RARA, RUNX1 (AML1), TNIP1, ZMYM2, ABL1, ASXL1, JAK2, JAK3, KRAS, MPL, NRAS, SETBP1, SF3B1, SH2B3, SRSF2
T-Cell Acute Lymphoblastic Leukemia (T-ALL)​
ABL1, AFDN, AGGF1, ASNS, BCL11B, BCR, CASC5, DDX3X, ETV6, JAK2, KMT2A, KMT2E, MLLT1, MLLT10, NOTCH1, NUP214, PBX1, RUNX1 (AML1), SALL2, SET, SPI1, STIL, STMN1, TAL1, TCF3, TCF7
Other Leukemias​
BCL11B, IKZF2, IKZF3, IRF2BP2, MYC, NPM1, PDCD1LG2, SETD2, TYK2
Chronic Neutrophilic Leukemia (CNL)​
CSF3R (GM-CSFR)
Multiple Myeloma​
ATM, BRAF, CDKN2A (P16INK4A), EGFR (ERBB1), FBXW7, HRAS, MYC, PTEN, SMARCB1
Myeloid Malignancies​
CBL, CBLB, DNMT3A, EZH2
Myelofibrosis​
CHEK2 (RAD53), IDH1, IDH2, SRSF2
Other Myeloid Neoplasms​
BRAF, CDKN2A (P16INK4A), CUX1, FBXW7, HRAS, MYD88, PTEN, STAT3
Lymphoma
Acute Lymphoblastic Lymphomas​
BCL11B, CREBBP (CBP), EBF1, KMT2A, MLLT10, MYC, P2RY8, PRDM16, STIL
Anaplastic Large Cell Lymphomas​
ADGRG7, ALK, ATIC, CLTC, MSN, MYC, NPM1, TFG, TPM3, TPM4, ALK, CDKN2A (P16INK4A), DNMT3A, NRAS, STAT3
Angioimmunoblastic T Cell Lymphomas​
CD28, CTLA4, FIP1L1, PDGFRA, ALK, APC, ARID1A, ASXL1, ATM, BRAF, CDKN2A (P16INK4A), CREBBP (CBP), CTNNB1, DNMT3A, EZH2, FBXW7, IDH2, JAK1, JAK3, KIT (CD117), KMT2D, KRAS, MED12, PLCG1, RHOA, STAT3, WT1, XPO1, ZFHX3
Burkitt Lymphomas​
BCL6, MYC, PBX1, TCF3, APC, ARID1A, ATM, CD79B, CDKN2A (P16INK4A), CREBBP (CBP), FBXW7, HLA-A, ID3, KRAS, MYC, MYD88, NRAS, PAX5, PIK3CA (p110-alpha), PIK3R1 (p85-ALPHA), PTEN, RHOA, SRSF2
Diffuse Large B Cell Lymphomas (DLBCL)​
ALK, BCL11A, BCL6, CCND3, CIITA, CLTC, IGLL5, LPP, MAPK13 (p38delta), MYC, NPM1, PIM1, REL, SQSTM1, TBL1XR1, TOMM40, TP63, ZCCHC7, ALK, AMER1, APC, ARID1A, ASXL1, ATM, B2M, BCL2, BCOR, BRAF, BTK, CD79B, CDKN2A (P16INK4A), CNOT3, CREBBP (CBP), CTNNB1, CXCR4, DNMT3A, EZH2, FBXW7, HLA-A, ID3, IDH2, IRS4, JAK1, JAK3, KIT (CD117), KMT2D, KRAS, MAP2K1, MED12, MSN, MYC, MYD88, NCOR1, NFKBIE, NOTCH2, NRAS, NSD2, PAX5, PIK3CA (p110-alpha), PIK3R1 (p85-ALPHA), PLCG1, POT1, PPM1D, PTEN, RGS7, RHOA, SF3B1, SMO, SRSF2, STAT3, STAT5B, STAT6, TERT, TRRAP, WT1, XPO1, ZFHX3, ZNF479
Follicular Lymphomas​
AFF3, BCL2, BCL6, CIITA, MYC, TBL1XR1, TP63, AMER1, ARID1A, ATM, B2M, BCL2, BCOR, BRAF, BTK, CD79B, CDKN2A (P16INK4A), CREBBP (CBP), CXCR4, DNMT3A, EZH2, FBXW7, ID3, IDH2, KMT2D, MAP2K1, MED12, MYD88, NOTCH2, NRAS, PIK3R1 (p85-ALPHA), PPM1D, PTEN, RGS7, RHOA, SRSF2, STAT6, ZMYM3
Granulocytic Sarcomas​
RUNX1 (AML1), RUNX1T1
Hodgkin Lymphomas​
ALK, CIITA, JAK2, NPM1, SEC31A, ARID1A, ASXL1, B2M, BCOR, CDKN2A (P16INK4A), DNMT3A, EZH2, NFKBIE, NRAS, PAX5, PIK3R1 (p85-ALPHA), PPM1D, SF3B1
Inflammatory Myofibroblastic Tumors​
ALK, DCTN1
Lymphoblastic Lymphomas​
BCR, CRLF2 (TSLPR), EPOR, ETV6, FGFR1, NOTCH1, PBX1, PDGFRB, RARA, ZCCHC7
Lymphoblastic T Cell Lymphomas​
BCR, ETV6, FGFR1, FIP1L1, LYN, PDGFRA
Mantle Cell Lymphomas​
CCND3, MYC, ARID1A, ASXL1, ATM, B2M, BCOR, BRAF, BTK, CDKN2A (P16INK4A), CREBBP (CBP), DNMT3A, IDH2, KMT2D, KRAS, MED12, NCOR1, NFKBIE, NOTCH2, NRAS, NSD2, PAX5, POT1, PPM1D, PTEN, STAT3, TERT, ZFHX3
Mediastinal Large B Cell Lymphomas (MLBL)​
CIITA, PDCD1LG2
Mucosa-Associated Lymphoid Tissue (MALT) Lymphomas​
BCL6, BIRC3 (c-IAP2), CCND3, MALT1, MYC, MYD88, NOTCH2
Peripheral T Cell Lymphomas​
ALK, ETV6, FGFR3, IKZF2, ITK, MYO1F, NPM1, S100A7, SYK, TBL1XR1, THAP4, TP63, VAV1, ALK, ARID1A, ASXL1, ATM, CDKN2A (P16INK4A), CTNNB1, DNMT3A, IDH2, IRS4, KIT (CD117), KMT2D, KRAS, MAP2K1, MSN, NRAS, PLCG1, PTEN, RGS7, RHOA, STAT3, STAT5B, TRRAP, XPO1, ZFHX3, ZNF479
Precursor T Cell Lymphoblastic Lymphomas​
ABL1, JAK2, NUP214, PCM1, SET, CTNNB1, FBXW7, NRAS, WT1
T Cell Lymphomas​
ATXN2L, BCL11B, FGFR1, IKZF2, JAK2
Other Lymphomas​
BCL6, BIRC3 (c-IAP2), CBFB, CCND1, CCND3, CDK6, CHIC2, DEK, DUSP22, EIF4A1, KMT2A, MALT1, MKL1, MLF1, MLLT10, MYC, NFKB2, PICALM, PRDM16
AIDS-Related Lymphomas​
EZH2
B Cell Lymphomas​
ARID1A, ATM, B2M, BCL2, BCOR, BRAF, CD79B, CDKN2A (P16INK4A), CREBBP (CBP), CTNNB1, CXCR4, DNMT3A, EZH2, JAK3, KIT (CD117), KMT2D, MAP2K1, MYD88, PIK3CA (p110-alpha), PPM1D, PTEN, RHOA, STAT3
Small Lymphocytic Lymphomas​
ALK, APC, ARID1A, ASXL1, ATM, BCL2, BCOR, BRAF, BTK, CD79B, CDKN2A (P16INK4A), CNOT3, CREBBP (CBP), CXCR4, DNMT3A, FBXW7, GNAS, IRS4, JAK1, JAK3, KIT (CD117), KMT2D, KRAS, MAP2K1, MED12, MSN, MYC, MYD88, NCOR1, NFKBIE, NOTCH2, NRAS, PAX5, PIK3CA (p110-alpha), PIK3R1 (p85-ALPHA), PLCG1, POT1, PPM1D, PTEN, RGS7, SF3B1, STAT5B, STAT6, TERT, TRRAP, XPO1, ZFHX3, ZMYM3, ZNF479
Cutaneous T Cell Lymphomas​
KRAS, PTEN
Diffuse Red Pulp Small B Cell Lymphomas​
MYD88, NOTCH2
Enteropathy-Type T Cell Lymphomas​
STAT5B
Gamma-Delta T Cell Lymphomas​
STAT3, STAT5B
Hepatosplenic T Cell Lymphomas​
STAT3, STAT5B
Lymphoplasmacytic Lymphomas​
ARID1A, BTK, CD79B, CXCR4, DNMT3A, MYD88
Marginal Zone Lymphomas​
AMER1, ARID1A, ASXL1, ATM, BRAF, CD79B, CREBBP (CBP), CXCR4, DNMT3A, EZH2, FBXW7, GNAS, JAK3, KIT (CD117), KMT2D, MAP2K1, MYD88, NFKBIE, NOTCH2, PIK3R1 (p85-ALPHA), RHOA, SRSF2, TRRAP, XPO1
Mycosis Fungoides (Sezary Syndrome)​
AMER1, ARID1A, ATM, BCOR, CDKN2A (P16INK4A), DNMT3A, JAK1, JAK3, KMT2D, KRAS, NCOR1, NRAS, PIK3CA (p110-alpha), PLCG1, POT1, PTEN, STAT3, STAT5B
NK-T Cell Lymphomas​
ALK, AMER1, APC, ARID1A, ASXL1, ATM, B2M, BCOR, BRAF, CTNNB1, DNMT3A, EZH2, FBXW7, HLA-A, JAK1, JAK3, KIT (CD117), KMT2D, KRAS, MED12, NCOR1, NOTCH2, NRAS, POT1, RGS7, RHOA, SMO, STAT3, STAT5B, WT1, XPO1, ZFHX3
Primary Central Nervous System Lymphomas​
B2M, BCL2, CD79B, CDKN2A (P16INK4A), CXCR4, DNMT3A, HLA-A, JAK3, KIT (CD117), KRAS, MYD88, NOTCH2, POT1, STAT3, STAT5B, TERT, TRRAP, WT1
Primary Effusion Lymphomas​
CDKN2A (P16INK4A), PTEN
Myelodysplastic Syndromes (MDS)
ABL1, ACTN4, ALK, CASC5, CREBBP (CBP), DEK, DIAPH2, ERG, ETV6, FGFR1, FRYL, FUS, GOT1, HOXA11, HOXA13, HOXD13, JAK2, KMT2A, LNP1, MAML2, MECOM, MLF1, MN1, MNX1, MYH11, NDE1, NPM1, NUP214, NUP98, PAN3, PCM1, PDGFRB, PRDM16, PSMA2, PTPRR, RANBP2, RUNX1 (AML1), RUNX1T1, SEPT9, SYK, TOP1, ZMYM2
Myeloproliferative Neoplasms
ABL1, ACSL6, BCR, CNTRL, ETV6, FGFR1, FGFR1OP, FIP1L1, FLT3, FOXP1, HOXA9, HOXD13, JAK2, KANK1, LYN, MECOM, MLF1, MN1, NPM1, NUP98, PCM1, PDGFRA, PDGFRB, PRKG2, PSIP1, RARA, RUNX1 (AML1), TNIP1
Other Hematological Malignancies
Eosinophilia​
ETV6, FOXP1, LYN, PDGFRA
Langerhans Cell Histiocytosis​
NTRK3, PLEKHA6
Plasma Cell Myelomas​
ABL1, BCR
Polycythemia Vera​
GTF2H3
Severe Thrombocythemia​
KANK1, PDGFRB
Other Myeloid Neoplasms
KLF2, PTK2B (PYK2), SEMA6A
Commercial Control Samples
ALK, BAIAP2L1, BRAF, CCDC6, CD74, EGFR (ERBB1), EML4, ERG, ETV6, FGFR3, KIF5B, LMNA, MET, NCOA4, NTRK1, NTRK3, PAX8, PPARG, RET, ROS1, SEPT14, SLC34A2, SLC45A3, TACC3, TFG, TMPRSS2, TPM3
General Leukemia Markers
ANPEP, CD19, CD200, CD33, CD34, CD38, CR2, FOXM1, FOXO3, HOXA9, ITGA6, KIT (CD117), MS4A1, RUNX1 (AML1)
Leukemia Subtype Markers
Acute Lymphoblastic Leukemia (ALL)​
ANPEP, BTG1, CASP8AP2, CD19, CD1A, CD2, CD22, CD33, CD5, CD7, CD79A, CD8A, CR2, ETV6, HLA-DRA, HLA-DRB1, IL2RA (CD25), JUN, KIT (CD117), LMO1, LMO2, LYL1, MEIS1, MME, MS4A1, MYC, PBX1, PTPRC, RB1, VEGFA, WT1
B Cell Acute Lymphoblastic Leukemia (B-ALL)​
BTG1, CD300A, CD72, CD79A, CD79B, CD86, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CRLF2 (TSLPR), EBF1, ETV6, HOXA9, IKZF1, PAX5, RB1
T Cell Acute Lymphoblastic Leukemia (T-ALL)​
BTK, CD27 (TNFRSF7), CD4, KCNN4, LMO1, LMO2, LYL1, MMP9, RUNX1 (AML1), SERPINI1, TAL1, THBS1 (TSP-1), TLX1, TLX3, VPREB3
Acute Myeloid Leukemia (AML)​
ADGRE5 (CD97), ASS1, BAALC, BCL11B, BIRC5, CD200, CD300A, CD44, CD86, CD96, CD99, CLEC12A, ERG, FCGR2A, FLT3, HAVCR2, IL2RA (CD25), JUN, KIT (CD117), KLF4, LEF1, MECOM, MEIS1, MMP9, NPM1, PTPRC, THBS1 (TSP-1), VEGFA, WT1
Chronic Lymphocytic Leukemia (CLL)​
ABCA6, AIM2, AKT1, BAX, BCL2, BIRC2 (c-IAP1), BTK, CD19, CD200, CD24, CD27 (TNFRSF7), CD5, CD79B, CXCR4, IL7, ITGA4 (CD49D), ITGAM, JUN, KCNN4, LAIR1, LEF1, MCL1, MMP9, MS4A1, ROR1, SERPINI1, SOX11, THBS1 (TSP-1), TNF, TTN, VEGFA, VPREB3, WNT3
Chronic Myeloid Leukemia (CML)​
AURKA, AURKB, IL2RA (CD25), JUN, KIT (CD117), PTCH1, PTPRC
Other Leukemia Subtypes​
CD72, IL2RA (CD25), SPI1
Leukemia Stem Cell & Proliferation Markers
ADGRG1, BAALC, BMI1, CD33, CD34, CD44, CD47, CD96, CD99, CLEC12A, CXCL12 (SDF1), CXCR4, ERG, FCGR2A, HAVCR2, IL2RA (CD25), IL3RA, KIT (CD117), KLF4, LAIR1, LIN28A, MYC, POU5F1 (OCT4), PTPRC, SOX2, THY1, WT1
Possible Prognostic Significance
Indicator of Clinical Outcome in Leukemia​
AURKB, BAALC, BIRC5, ERG, FOXO3, GATA2, MECOM, MEIS1, RUNX1 (AML1), SPI1, WT1
Acute Lymphoblastic Leukemia (ALL)​
ABCB1 (MDR1, PGY1), AKT1, ANPEP, BIRC5, CD33, CD3D, CD44, FLT3, HOXA9, IKZF1, JUN, MME, MYC, PAX5, SMYD2
B Cell Acute Lymphoblastic Leukemia (B-ALL)​
ANPEP, CD33, CRLF2 (TSLPR), JUN, MS4A1
T Cell Acute Lymphoblastic Leukemia (T-ALL)​
BCL11B, BMI1, LMO1, LMO2, LYL1, MYC, TAL1, TLX1, TLX3
Acute Myeloid Leukemia (AML)​
ABCB1 (MDR1, PGY1), ANGPT2, BAALC, BCL2, BIRC2 (c-IAP1), BIRC5, BMI1, CCNA1, CD200, CD34, CD4, CD44, CD47, CD96, CLEC12A, CXCL12 (SDF1), CXCR4, ERG, GATA2, HAVCR2, HGF, IL2RA (CD25), IL3RA, KLF4, LEF1, MECOM, MEIS1, MN1, MYC, RUNX1 (AML1), SOX11, SOX2, SPI1, WT1, XIAP
Chronic Lymphocytic Leukemia (CLL)​
ABCA6, ANGPT2, BCL2, CD24, CD38, CD69, ITGA4 (CD49D), KCNN4, LAIR1, LPL, MS4A1, MYC, NOTCH1, ROR1, SOX11, TTN, UGT2B17, VPREB3, WNT3, ZAP70
Chronic Myeloid Leukemia (CML)​
AURKA, AURKB, LIN28A, MCL1, PTCH1
Chemotherapy Resistance Related​
AKT1, AURKB, BAALC, BCL2, BIRC2 (c-IAP1), CD274 (PD-L1), CD274 (PD-L1), CD44, CD47, ERG, HLA-DRA, HLA-DRB1, IL3RA, MCL1, MYC, XIAP
Hypoxia & Oxidative Stress Related​
ANGPT2, VEGFA
Treatment Target or Treatment Indicator​
ASS1, BMI1, CASP8AP2, CD33, CD47, CD69, CD96, CDC25A, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CLEC12A, CXCR4, FLT3, FOXM1, FOXO3, HAVCR2, IL3RA, ITGAM, KLF4, LMO2, MS4A1, MYC, PTCH1, SERPINI1, SMARCA4, TAL1, ZAP70
Associated with Invasiveness or Infiltration into Central Nervous System​
CXCL12 (SDF1), CXCR4, ZAP70
Minimal Residual Disease​
ADGRE5 (CD97), BAALC, BCL2, CD19, CD200, CD24, CD300A, CD44, CD47, CD69, CD72, CD79B, CD86, CD99, CLEC12A, HAVCR2, IL2RA (CD25), IL3RA, ITGA6, NPM1, PBX1, WT1
Mechanistic Role in Pathogenesis
BCL11B, BCL2, BMI1, ERG, FOXM1, GATA2, HOXA9, LMO2, LPL, MEIS1, NOTCH1, PAX5, SPI1, TAL1, TLX1, TLX3, TNF, VEGFA, WT1
Expression Altered due to Genetic Alterations
Acute Lymphoblastic Leukemia (ALL)​
AHI1, BCL11A, BCL2, BCL9, BRD4, CCND2, CEBPA, CEBPB, CEBPD, CEBPE, CEBPG, CRLF2 (TSLPR), EPOR, ETV6, HOXA1, ID4, IGF2BP1, IL3, IRF4, IRS4, LCK, LHX4, LMO1, LMO2, LYL1, MYB, MYC, NKX2-5, NOTCH1, OLIG2, TAL2, TLX1, TLX3
Acute Myeloid Leukemia (AML)​
MECOM, NKX2-5, RANBP17, TCL1A, TLX3
Lymphoma​
BCL10, BCL2, BCL3, BCL6, BCL9, CCND1, CCND2, CCND3, CD44, CDK6, ERVW-1, FCGR2B, FCRL4, FOXP1, GPR34, IRF4, KDSR, MALT1, MTCP1, MUC1 (mucin), MYC, NBEAP1, NFKB2, PAX5, PRDM16
Myelomas​
FGFR3, MAF, MAFB, NSD2
Other Leukemia Subtypes & Other Genetic Alterations​
BAALC, BCL11B, CRLF2 (TSLPR), ERG, KIT (CD117), LMO1, LPL, NPM1, TAL1, ZAP70

Product Resources

Detailed Target List for each Analyte
File Size: 37.24 KBLanguage: English

Resources

Safety Data Sheets (1)
Kit Handbooks (1)
Template Files (1)
Certificates of Analysis (1)
Introducing the QIAseq RNA Fusion XP Pan Heme Panel, a cutting-edge addition to our QIAseq RNA Fusion XP Panels lineup, specifically designed for {{application}} applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq RNA Fusion XP Pan Heme Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting {{application}}, or any other sophisticated analyses, this product from our QIAseq RNA Fusion XP Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq RNA Fusion XP Pan Heme Panel and elevate your work to new heights.